Vaxart Inc. [NASDAQ: VXRT] stock went on a downward path that fall over -5.57% on Tuesday, amounting to a one-week price decrease of less than -26.88%. The company report on August 25, 2020 that VAXART ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Vaxart, Inc. and Encourages Investors to Contact the Firm.
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors that purchased Vaxart, Inc. (NASDAQ: VXRT) securities between June 25, 2020 and July 25, 2020 (the “Class Period”). Investors have until October 23, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Click here to participate in the action.
Over the last 12 months, VXRT stock rose by 948.27%. The average equity rating for VXRT stock is currently 2.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $813.43 million, with 109.20 million shares outstanding and 108.18 million shares in the current float. Compared to the average trading volume of 26.22M shares, VXRT stock reached a trading volume of 10614392 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Vaxart Inc. [VXRT]:
H.C. Wainwright have made an estimate for Vaxart Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 12, 2020. While these analysts kept the previous recommendation, B. Riley FBR raised their target price to Buy. The new note on the price target was released on July 13, 2020, representing the official price target for Vaxart Inc. stock.
The Average True Range (ATR) for Vaxart Inc. is set at 1.23, with the Price to Sales ratio for VXRT stock in the period of the last 12 months amounting to 104.29. The Price to Book ratio for the last quarter was 12.87, with the Price to Cash per share for the same quarter was set at 0.38.
VXRT Stock Performance Analysis:
Vaxart Inc. [VXRT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -26.88. With this latest performance, VXRT shares dropped by -37.72% in over the last four-week period, additionally plugging by 321.21% over the last 6 months – not to mention a rise of 948.27% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VXRT stock in for the last two-week period is set at 37.30, with the RSI for the last a single of trading hit 28.55, and the three-weeks RSI is set at 42.08 for Vaxart Inc. [VXRT]. The present Moving Average for the last 50 days of trading for this stock 9.11, while it was recorded at 8.11 for the last single week of trading, and 3.39 for the last 200 days.
Insight into Vaxart Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Vaxart Inc. [VXRT] shares currently have an operating margin of -110.17. Vaxart Inc.’s Net Margin is presently recorded at -189.06.
Return on Total Capital for VXRT is now -33.85, given the latest momentum, and Return on Invested Capital for the company is -67.27. Return on Equity for this stock declined to -154.15, with Return on Assets sitting at -51.61. When it comes to the capital structure of this company, Vaxart Inc. [VXRT] has a Total Debt to Total Equity ratio set at 143.95. Additionally, VXRT Total Debt to Total Capital is recorded at 59.01, with Total Debt to Total Assets ending up at 50.35. Long-Term Debt to Equity for the company is recorded at 114.95, with the Long-Term Debt to Total Capital now at 47.12.
Reflecting on the efficiency of the workforce at the company, Vaxart Inc. [VXRT] managed to generate an average of -$1,331,786 per employee. Receivables Turnover for the company is 3.64 with a Total Asset Turnover recorded at a value of 0.27.Vaxart Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.00 and a Current Ratio set at 4.00.
VXRT Stock EPS
With the latest financial reports released by the company, Vaxart Inc. posted -0.32/share EPS, while the average EPS was predicted by analysts to be reported at -0.35/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 8.60%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VXRT.
Vaxart Inc. [VXRT] Insider Position Details
There are presently around $136 million, or 21.80% of VXRT stock, in the hands of institutional investors. The top three institutional holders of VXRT stocks are: BLACKROCK INC. with ownership of 3,366,657, which is approximately 550.396% of the company’s market cap and around 0.50% of the total institutional ownership; CITADEL ADVISORS LLC, holding 3,096,964 shares of the stock with an approximate value of $21.52 million in VXRT stocks shares; and VR ADVISER, LLC, currently with $19.22 million in VXRT stock with ownership of nearly New of the company’s market capitalization.
Positions in Vaxart Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 71 institutional holders increased their position in Vaxart Inc. [NASDAQ:VXRT] by around 16,278,822 shares. Additionally, 15 investors decreased positions by around 27,093,238 shares, while 7 investors held positions by with 23,791,353 shares. The mentioned changes placed institutional holdings at 19,580,707 shares, according to the latest SEC report filing. VXRT stock had 56 new institutional investments in for a total of 10,811,308 shares, while 8 institutional investors sold positions of 128,692 shares during the same period.